期刊文献+

活体冷冻技术在评估小鼠心脏缺血再灌注损伤中的应用 被引量:1

Application of in vivio cryotechnique in the assessment of myocardial ischemia reperfusion injury in mice
原文传递
导出
摘要 目的:探讨活体冷冻技术在评估小鼠心脏缺血再灌注损伤中的应用。方法:将36只小鼠随机分为假手术组(C组)、缺血组(I组)、再灌注0 min组(I/R 0 min组)、再灌注15 min组(I/R 15 min组)、再灌注1 h组(I/R 1 h组)、再灌注前2 h阿托伐他汀10 mg·kg-1灌胃组(A102组)、再灌注前2 h阿托伐他汀20 mg·kg-1灌胃组(A202组)、再灌注前12 h阿托伐他汀20 mg·kg-1灌胃组(A2012组)、再灌注前2 h阿托伐他汀20 mg·kg-1灌胃+再灌注前15 min L-NAME(N-硝基-L-精氨酸甲酯)15 mg·kg-1尾静脉注射组(AL202组)等9组,每组均4只小鼠。于光镜下结扎冠状动脉制备心肌缺血再灌注模型,均以活体冷冻技术(in vivo cryotechnique,IVCT)摘取心脏后行冷冻置换、石蜡包埋,之后切片进行HE染色及Albumin免疫组织化学染色,并对间质中的Albumin免疫组织化学染色强度进行半定量分析。结果:(1)相比C组,I组可见心肌微血管内红细胞明显减少或缺如,心肌细胞肿胀,Albumin向间隙内明显渗出。I/R 0 min组血流恢复情况尚可,Albumin无明显向间质等部位渗漏;I/R 15 min组及I/R 1 h组可见随再灌注时间的延长,心肌细胞及微血管内红细胞形态渐趋肿胀、紊乱、破碎,Albumin向间隙内的渗漏明显增多。(2)与I/R 1 h组相比,A202组心肌细胞界限较清晰,微血管内红细胞形态正常,Albumin无明显向间质等部位渗漏。A102组及A2012组镜下所见与A202组类似,但微血管内红细胞形态及心肌细胞界限、Albumin向间质的渗漏程度等不及A202组。AL202组可见心肌细胞肿胀,微血管内红细胞减少、缺如,但微循环血流及Albumin渗漏情况仍优于I/R组。结论:应用IVCT可直观评估小鼠缺血及再灌注过程中心脏微循环状态及微血管渗透性变化。再灌注前2 h应用阿托他汀强化治疗可改善缺血再灌注心脏微循环状态及微血管渗透性。 Objective: To analyze the state of microcirculation and microvascular permeability during myocardial ischemia reperfusion by using in vivio cryotechnique (IVCT). Methods: Thirty- six mice were divided into 9 groups randomly : sham- operated ( C ) group, ischemia ( I ) group, ischemia- reperfusion 0 min ( I/R 0 min ) group,ischemia-reperfusion 15 min (I/R 15 min)group, ischemia-reperfusion 1 h (I/R 1 h)group, atorvastatin 10 mg · kg- 1 gavage 2 h before reperfusion (A102)group, atorvastatin 20 mg · kg-1 gavage 2 h before reperfusion (A202) group, atorvastatin 20 mg· kg-1 gavage 12 h before reperfusion (A2012)group, atorvastatin 20 mg· kg-1 gavage 2 h before reperfusion +L-NAME 15 mg · kg-1 tail vein injection 15 min before reperfusion (AL202) group. The myocardial ischemia reperfusion model was prepared under light microscopy. IVCT followed by freeze-substitution fixation was used to prepare the heart sample, and then stained with hematoxylin-eosine (HE) and albumin antibody for light microscopy observation. Results : ( 1 ) Compared with C group, I and I/R 1 h group showed that the amount of erythrocyte was decreased or absent in microvasculatures, and albumin was obviously immunolocalized in interstitium. (2) Compared with I/R 1 h group, A202 group showed a more clear structure of microenvironment, a better blood flow in microvascular and less leakage of albumin in the blood vessel. A102 group and A2012 group showed a similar effect, but less than A202 group. AL202 group showed a slightly narrow myocardial microvascular and myocardial cell swelling, but the blood flow and leakage of plasma albumin were less than those in I/R group. Conclusion: IVCT could morphofunctionally and immunohistochemically display the circulation and permeability of microvascular in ischemia-reperfusion mouse heart. Pretreatment with atorvastatin 2 h before reperfusion could significantly improve the blood flow state and the plasma albumin leakage of microvascular.
出处 《现代医学》 2016年第4期445-449,共5页 Modern Medical Journal
基金 国家自然科学基金青年科学基金项目(81200083) 心肌缺血省部共建教育部重点实验室开放课题项目(KF201312)
关键词 活体冷冻技术 心脏组织 缺血再灌注 血管渗透性 小鼠 in vivo cryotechnique heart tissue ischemia reperfusion microvascular permeability mice
  • 相关文献

参考文献7

  • 1可庆恩,杨寅柯,Jamal S.RANA,陈玉,James P.MORGAN,萧永福.培养于生物降解支架膜内的胚胎干细胞可修复小鼠的梗塞心肌(英文)[J].生理学报,2005,57(6):673-681. 被引量:15
  • 2TUUMINEN R.SYRJALA S’KREBS R,et al. Donor simvasta-tin treatment abolishes rat cardiac allograft ischemia/reperfu-sion injury and chronic rejection through microvascular protec-tion[ J]. Circulation,2011,124( 10) :1138-1150.
  • 3HORIUCHI Y,HIRAYAMA S,S0DA S,et al. Statin therapyreduces inflammatory markers in hypercholesterolemic patientswith high baseline levels[ J]. J Atheroscler Thromb,2010,17(7):722-729.
  • 4Di SCIASCIO G,PATTI G,PASCERI V,et al. Efficacy of ator-vastatin reload in patients on chronic statin therapy undergoingpercutaneous coronary intervention : results of the ARMYDA-RECAPTURE ( Atorvastatin for Reduction of Myocardial Dam-age During Angioplasty) Randomized Trial[J].J Am Coll Car-diol, 2009,54(6) :558-565.
  • 5SUN Y,QI G,GAO Y,et al. Effect of different loading doses ofatorvastatin on percutaneous coronary intervention for acutecoronary syndromes[ J]. Gan J Cardiol,2010,26(9) :481-485.
  • 6焦云根,刘乃丰,孙晓宁,张振刚.老年NSTEACS患者PCI术前负荷量瑞舒伐他汀对血清Lox-1、hs-CRP及近期预后的影响[J].东南大学学报(医学版),2015,34(1):71-76. 被引量:6
  • 7BALAKUMAR P,KATHURIA S,TANEJA G,et al. Is targetingeNOS a key mechanistic insight of cardiovascular defensive po-tentials of statins? [ J]. J Mol Cell Cardiol,2012,52( 1) :83-92.

二级参考文献43

  • 1Muller-Ehmsen J,Kedes LH,Schwinger RH,Kloner RA.Cellular cardiomyoplasty-a novel approach to treat heart disease.Congest Heart Fail 2002; 8:220-227.
  • 2Min JY,Yang Y,Converso KL,LiuL,Huang Q,Morgan JP,Xiao YF.Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats.J Appl Physiol 2002; 92:288-296.
  • 3Yang Y,Min JY,Rana JS,Ke Q,Cai J,Chen Y,Morgan JP,Xiao YF.VEGF enhances functional improvement of postinfarcted hearts by transplantation of ESC-differentiated cells.J Appl Physiol2002; 93:1140-1151.
  • 4Strauer BE,Brehm M,Zeus T,Kostering M,Hemandez A,Sorg RV,Kogler G,Wemet P.Repair of infarcted myocardium by autologous intracoronary mononuclear bonemarrow cell transplantation in humans.Circulation 2002; 106:1913-1918.
  • 5Leor J,Aboulafia-Etzion S,Dar A,Shapiro L,Barbash IM,Battler A,Granot Y,Cohen S.Bioengineered cardiac grafts:A new approach to repair the infracted myocardium? Circulation 2000;102:Ⅲ56-Ⅲ61.
  • 6Li RK,Yau TM,Weisel RD,Mickle DA,Sakai T,Choi A,Jia ZQ.Construction of a bioengineered cardiac graft.J Thorac Cardiovasc Surg 2000; 119:368-375.
  • 7Orlic D,Kajstura J,Chimenti S,Limana F,Jakonink I,Quaini F,Nadal-Ginard B,Bodine DM,Leri A,Anversa P.Mobilized bone marrow cells repair the infarcted heart,improving function and survival.Proc Natl Acad Sci USA 2001; 98:10344-10349.
  • 8Komowski R,Fuchs S,Leon MB,Epstein SE.Delivery strategies to acineve therapeutic myocardial angiogenesis.Circulation 2000;101:454-458.
  • 9Stock UA,Sakamoto T,Hatsuoka S,Martin DP,Nagashima M,Moran AM,Moses MA,Khalil PN,Schoen FJ,Vacanti JP,Mayer JE Jr.Patch augmentation of the pulmonary artery with bioabsorbable polymers and autologous cell seeding.J Thorac Cardiovasc Surg 2000; 120:1158-1167.
  • 10Ozawa T,Mickle DA,Weisel RD,Koyama N,Ozawa S,Li RK.Optimal biomaterial for creation of autologous cardiac grafts.Circulation 2002; 106(12 Suppl 1):Ⅰ176-Ⅰ182.

共引文献19

同被引文献19

引证文献1

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部